Loading
Latest filing published 18 Jan 2024 for Innoveren Scientific, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by J. Rex Farrior III on record concern H-Cyte, Inc., in the capacity of chief executive. The record holds 3 filings, for trades running from 23 July 2020 to 16 January 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 18 January 2024 with a transaction in H-Cyte, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations